– Collaboration leverages Ascendis’ proprietary TransCon™ technologies and Novo Nordisk’s expertise in cardiometabolic diseases
Tag: Ascendis
Recent
Centerline Biomedical Appoints Jim Dillon President and Chief Executive Officer
Philips Announces Plan for More Than USD 150 Million of New Investment in Manufacturing and R&D in the U.S. to Expand Production of AI-powered Health Technology Innovations
Simpson Interventions Announces First Patients Treated in Clinical Trial for its Acolyte™ Catheter System
Popular
- No commented posts yet